Exosome mediated Metastasis Analysis Service

Creative Biolabs provides an end-to-end platform for the isolation, characterization, and deep-learning analysis of tumor-derived exosomes. We provide researchers with high-purity extracellular vesicle fractions and detailed molecular maps of their cargo, including proteins, nucleic acids, and surface markers. By utilizing our service, clients gain a clear understanding of the signaling pathways driving the pre-metastatic niche, enabling the identification of novel drug targets and the validation of therapeutic strategies in preclinical models.

Introduction What We Can Offer How We Can Help Why Choose Us Customer Reviews FAQs Related Services Contact Us

Introduction to Exosome-mediated Metastasis Analysis

Exosomes are nano-sized vesicles that serve as systemic signalosomes within the tumor microenvironment. Research confirms they carry pro-EMT programs and oncoproteins that "educate" bone marrow progenitors and license the pre-metastatic niche. By hijacking systemic metabolism and interacting with biological barriers, these vesicles facilitate organotropic colonization. Creative Biolabs utilizes these mechanisms to provide a detailed view of cancer progression in research models, transforming these biological "messages" into opportunities for precision oncology research.

Request a Consultation →

Fig 1. Exosomes in the tumor microenvironment mainly complete information exchange and material transportation between tumor cells. (OA Literature)Fig.1 Exosomes participate in cancer metastasis. 1

What We Can Offer

High-Resolution Omics Mapping

We perform multidimensional profiling of exosomal proteins, miRNAs, and double-stranded DNA to deliver a complete molecular fingerprint of tumor-derived vesicles in various research settings.

Customized Isolation Protocols

Our team develops tailored isolation strategies optimized for challenging matrices, ensuring high-yield recovery from cell culture supernatants and diverse experimental biofluids without compromising vesicle integrity.

Organotropic Integrin Sequencing

We identify tissue-specific "zip codes" on the exosomal surface, enabling the mapping of the trajectory of pre-metastatic niche formation across diverse animal models.

Scalable Analytical Capacity

We support everything from exploratory pilot studies to large-scale research cohorts, leveraging high-throughput workflows that ensure consistent, high-purity results across all sample sets.

How Creative Biolabs Can Assist Your Project

Core steps of exosome mediated metastasis analysis. (Creative Biolabs Original)

Highlights

Superior Isolation Technology

Creative Biolabs utilizes proprietary SEC-Affinity methods to eliminate lipoprotein and albumin contamination, providing an exceptionally clean molecular background for high-sensitivity downstream proteomic and genomic analysis.

Deep Biological Context

Our experts leverage established research on MET-driven bone marrow reprogramming to provide meaningful context to your data, ensuring results are integrated into the wider metastatic framework.

Service Features

High-Impact Research Support

Our detailed data packages are specifically structured to support rigorous academic peer-review and facilitate high-impact publications, as well as early-stage industrial drug discovery and target validation.

Customized Analytical Interpretation

We provide bespoke bioinformatics and pathway mapping that translates raw exosomal cargo data into functional insights, allowing for the precise identification of novel experimental therapeutic targets.

By partnering with Creative Biolabs, you gain access to a specialized analytical environment where high-purity isolation meets deep biological interpretation - Get a Quote Today.

Customer Reviews

FAQs

How does your exosome isolation compare to standard ultracentrifugation?

While ultracentrifugation is common, it often causes vesicle aggregation. Creative Biolabs uses a hybrid SEC-affinity approach that ensures structural integrity and high purity, which is critical for accurate research proteomics.

Can your service detect mutations in models with low tumor burden?

Yes. Exosomal dsDNA is stable and often present at usable concentrations, making it an excellent tool for early detection and monitoring in experimental settings.

Related Services

Immune Checkpoint Assay Service

This service provides high-sensitivity screening and functional validation of exosomal checkpoint markers, utilizing advanced assay platforms to evaluate molecular interactions that facilitate immune evasion in tumor models.

Learn More →

Integrated Multi-Omics & Metastasis Risk Stratification

We combine deep proteomic and genomic profiling to deliver a hierarchical risk assessment of metastatic potential, enabling the identification of key driver pathways within complex research datasets.

Learn More →

How to Contact Us

Creative Biolabs provides a unique window into the systemic drivers of cancer progression by deconstructing the complex "soil" preparation that precedes visible secondary growth. By integrating high-purity isolation with multi-omics and genomic analysis, we empower researchers to intercept metastatic signaling before it can effectively take hold in distal organ models.

Our experts are available to help you design a study that maximizes the scientific impact of your exosomal data. Whether you are validating a novel biogenesis target or mapping a pre-metastatic niche, we provide the technical depth required to move your project forward. - Get Started Today.

Reference

  1. Zhong, Yunbin et al. "Exosomes: A New Pathway for Cancer Drug Resistance." Frontiers in oncology vol. 11 743556. 24 Sep. 2021. Distributed under an Open Access license CC BY 4.0, without modification. https://doi.org/10.3389/fonc.2021.743556
Loading case studies...
Online Inquiry